The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gautam, A. M.
Right arrow Articles by Glynn, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gautam, A. M.
Right arrow Articles by Glynn, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Dietary Proteins

The Journal of Immunology, Vol 144, Issue 4 1177-1180, Copyright © 1990 by American Association of Immunologists


ARTICLES

Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T cells

AM Gautam and P Glynn
Multiple Sclerosis Society Laboratory, Institute of Neurology, London, UK.

Experimental autoimmune encephalomyelitis (EAE) is an inflammatory neurological disease initiated by activated T cells specific for the autoantigen, myelin basic protein (MBP). The ability of Lewis rat splenic T cells to transfer EAE after in vitro incubation with MBP- pulsed dendritic cells (DC) was used as an index of MBP-specific T cell activation. OVA, previously processed by macrophages, was incubated with MBP and DC at the pulsing stage to determine whether it could inhibit presentation of the autoantigen. At molar equivalents of 2.5:1 and 20:1 relative to MBP, processed OVA increasingly inhibited the ability of DC to activate MBP-specific T cells for EAE transfer. Unprocessed OVA, which cannot be presented immunogenically by Lewis rat DC, was much less effective. However, processed OVA added to DC after they had been pulsed with MBP could not compete. OVA also blocked appearance of EAE when mixed with MBP/CFA in the inoculum used for active induction of the disease. Splenic T cells from MBP + OVA/CFA- immunized rats transferred EAE with a substantially delayed onset, suggesting that a reduced number of MBP-specific T cells was generated by immunizing with the OVA + MBP mixture compared with MBP alone. Overall, the data indicate that fragments of a foreign protein, OVA, which can be bound by APC, can also inhibit presentation of encephalitogenic determinants of MBP to T cells.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Fridkis-Hareli, E. F. Rosloniec, L. Fugger, and J. L. Strominger
Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones
PNAS, October 13, 1998; 95(21): 12528 - 12531.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Gautam, R. Liblau, G. Chelvanayagam, L. Steinman, and T. Boston
A Viral Peptide with Limited Homology to a Self Peptide Can Induce Clinical Signs of Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 1998; 161(1): 60 - 64.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. McLean, M. M. Rosado, F. Agenes, R. Vasconcellos, and A. A. Freitas
Resource competition as a mechanism for B cell homeostasis
PNAS, May 27, 1997; 94(11): 5792 - 5797.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Katz-Levy, M. Paas-Rozner, S. Kirshner, M. Dayan, E. Zisman, M. Fridkin, I. Wirguin, M. Sela, and E. Mozes
A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses
PNAS, April 1, 1997; 94(7): 3200 - 3205.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.